These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33847358)

  • 1. Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways.
    Hassan HM; Mahran YF; Ghanim AMH
    J Pharm Pharmacol; 2021 Aug; 73(9):1250-1261. PubMed ID: 33847358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PKC/TLR-4/NF-kB signaling by sulbutiamine improves diabetic nephropathy in rats.
    Ghaiad HR; Ali SO; Al-Mokaddem AK; Abdelmonem M
    Chem Biol Interact; 2023 Aug; 381():110544. PubMed ID: 37224990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
    Lu HJ; Tzeng TF; Liou SS; Da Lin S; Wu MC; Liu IM
    BMC Complement Altern Med; 2014 Mar; 14():110. PubMed ID: 24666993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
    Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
    Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
    Zhang H; Yang Y; Wang Y; Wang B; Li R
    Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR/NF-κB pathway.
    Wang HQ; Wang SS; Chiufai K; Wang Q; Cheng XL
    Chin J Nat Med; 2019 May; 17(5):346-354. PubMed ID: 31171269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways.
    Li J; Bao L; Zha D; Zhang L; Gao P; Zhang J; Wu X
    Int Immunopharmacol; 2018 Feb; 55():9-19. PubMed ID: 29207360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats.
    Eisa NH; Khodir AE; El-Sherbiny M; Elsherbiny NM; Said E
    Biomed Pharmacother; 2021 Oct; 142():111666. PubMed ID: 34215478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
    Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats.
    Abou-Hany HO; Atef H; Said E; Elkashef HA; Salem HA
    Chem Biol Interact; 2018 Mar; 284():90-100. PubMed ID: 29409856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abietic acid ameliorates nephropathy progression via mitigating renal oxidative stress, inflammation, fibrosis and apoptosis in high fat diet and low dose streptozotocin-induced diabetic rats.
    Wahab NAA; Giribabu N; Kilari EK; Salleh N
    Phytomedicine; 2022 Dec; 107():154464. PubMed ID: 36215789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease.
    Liu Y; Hu Z; Xing H; Kang L; Chen X; Liu B; Niu K
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):1-9. PubMed ID: 36332469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
    Mulay SR; Gaikwad AB; Tikoo K
    Chem Biol Interact; 2010 Apr; 185(2):137-42. PubMed ID: 20223228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.
    Chen J; Hu Y; Mou X; Wang H; Xie Z
    Life Sci; 2021 Jan; 265():118835. PubMed ID: 33253723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
    Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
    Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
    Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
    Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
    Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.